Cuvitus (Piper nigrum)

Cuvitus is a specialized extract from Piper nigrum (black pepper) designed to enhance piperine solubility and bioavailability. The extraction process increases piperine concentration, potentially improving its ability to inhibit drug-metabolizing enzymes and enhance nutrient absorption.

Origin & History

Cuvitus is a branded extract of piperine derived from black pepper (Piper nigrum), a perennial climbing vine native to India and Southeast Asia. The extract is produced through methods like aqueous hydrotrope extraction or ethanol-based extraction (96% ethanol, 1:3.9 ratio, yielding ~8 mg/g dry matter), standardizing the natural piperine content which occurs at 6-9% in black pepper fruits.

Historical & Cultural Context

Traditional medicine contexts for Piper nigrum or piperine use in systems like Ayurveda or Traditional Chinese Medicine are not covered in the available research. The focus remains on modern extraction techniques without historical perspective.

Health Benefits

• No clinical health benefits documented - the available research focuses exclusively on extraction chemistry rather than human efficacy data
• Bioavailability enhancement potential suggested by extraction methods that improve piperine solubility, though no clinical evidence provided
• Traditional use in Ayurvedic and TCM practices not documented in current research
• Safety profile remains unestablished due to absence of toxicological data
• Drug interaction potential unknown as no contraindication studies included

How It Works

Cuvitus delivers enhanced piperine that inhibits cytochrome P450 enzymes and P-glycoprotein transporters in the intestinal wall. This inhibition reduces first-pass metabolism and increases absorption of co-administered compounds. The specialized extraction improves piperine solubility, potentially increasing its bioactive concentration at absorption sites.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses for Cuvitus or piperine were identified in the research dossier. The available literature focuses exclusively on extraction methodologies and chemical characterization rather than clinical efficacy data.

Clinical Summary

No clinical trials have evaluated Cuvitus specifically in human subjects. Available research focuses exclusively on extraction chemistry and analytical methods rather than efficacy outcomes. While traditional piperine has demonstrated bioavailability enhancement in clinical studies, Cuvitus lacks independent human data. The enhanced extraction process suggests improved bioactivity, but this requires clinical validation.

Nutritional Profile

Cuvitus (Piper nigrum) is a proprietary or regional designation for black pepper, with nutritional composition reflecting standard Piper nigrum fruit. Per 100g dried black pepper: Calories ~251 kcal, Carbohydrates ~64g (including dietary fiber ~25g), Protein ~10g, Fat ~3.3g (primarily unsaturated fatty acids including oleic and linoleic acid). Key micronutrients include Manganese (~12.7mg, ~553% DV), Vitamin K (~163mcg), Iron (~9.7mg), Copper (~1.3mg), Magnesium (~171mg), Phosphorus (~158mg), and Potassium (~1329mg). Primary bioactive compound is Piperine (alkaloid fraction) at approximately 5-9% dry weight in whole peppercorns, responsible for characteristic pungency and documented bioavailability-enhancing properties — notably increasing absorption of curcumin by up to 2000% and enhancing selenium, B-vitamin, and beta-carotene absorption via inhibition of intestinal and hepatic glucuronidation. Additional bioactives include chavicine (geometric isomer of piperine), piperyline, piperettine, and volatile essential oils (~1-2.5% including sabinene, limonene, and beta-caryophyllene). The 'Cuvitus' designation likely refers to a standardized or enhanced extract form, potentially concentrating piperine content beyond natural levels; specific concentration data for this proprietary form is not publicly established in peer-reviewed literature.

Preparation & Dosage

No clinically studied dosage ranges are available in the research. Extraction yields reference ~8 mg piperine per gram of dry matter from optimized processes, but therapeutic dosing has not been established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not established - no synergistic combinations documented in research

Safety & Interactions

Safety data specific to Cuvitus is not available from clinical studies. Based on piperine research, potential interactions may occur with medications metabolized by CYP3A4, including blood thinners, seizure medications, and certain antibiotics. Gastrointestinal irritation may occur at high doses. Pregnant and nursing women should avoid use due to insufficient safety data.